Hans Biomed Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 263

Employees

  • Stock Symbol
  • 042520

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $6.55
  • (As of Friday Closing)

Hans Biomed General Information

Description

Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.

Contact Information

Formerly Known As
Hans Medical
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 7, Jeongui-ro 8-gil, Songpa-gu
  • Seoul, 05836
  • South Korea
+82
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 7, Jeongui-ro 8-gil, Songpa-gu
  • Seoul, 05836
  • South Korea
+82

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hans Biomed Stock Performance

As of 20-Jun-2025, Hans Biomed’s stock price is $6.55. Its current market cap is $85.1M with 13M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.55 $6.52 $4.15 - $9.14 $85.1M 13M 28.2K -$0.37

Hans Biomed Financials Summary

As of 31-Mar-2025, Hans Biomed has a trailing 12-month revenue of $60.5M.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 30-Sep-2024 FY 2023 30-Sep-2023 FY 2022 30-Sep-2022
EV 82,035 119,889 179,486 95,644
Revenue 60,474 60,303 59,248 59,673
EBITDA 1,182 363 (9,794) 11,627
Net Income (4,747) (5,368) (17,497) 4,926
Total Assets 87,397 92,820 90,653 92,034
Total Debt 29,356 27,781 30,478 39,074
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hans Biomed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hans Biomed‘s full profile, request access.

Request a free trial

Hans Biomed Patents

Hans Biomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4183369-A1 Breast implant having waviness Pending 17-Jul-2020
US-20230301771-A1 Breast implant having waviness Pending 17-Jul-2020
EP-4183369-A4 Breast implant having waviness Pending 17-Jul-2020
US-20220265279-A1 Anchor for embolic coils, and embolic coil comprising same Inactive 17-Jul-2019
ES-2644534-T3 Medical suture with microdientes on the surface and procedure to manufacture it Active 24-Mar-2011 D01D5/00
To view Hans Biomed’s complete patent history, request access »

Hans Biomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hans Biomed Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hans Biomed‘s full profile, request access.

Request a free trial

Hans Biomed Investments (2)

Hans Biomed’s most recent deal was a Joint Venture with Levos. The deal was made on 08-Jul-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Levos 08-Jul-2022 Joint Venture Other Pharmaceuticals and Biotechnology
Atems 01-Jul-2019 Early Stage VC Therapeutic Devices
To view Hans Biomed’s complete investments history, request access »

Hans Biomed FAQs

  • When was Hans Biomed founded?

    Hans Biomed was founded in 1993.

  • Where is Hans Biomed headquartered?

    Hans Biomed is headquartered in Seoul, South Korea.

  • What is the size of Hans Biomed?

    Hans Biomed has 263 total employees.

  • What industry is Hans Biomed in?

    Hans Biomed’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Hans Biomed a private or public company?

    Hans Biomed is a Public company.

  • What is Hans Biomed’s stock symbol?

    The ticker symbol for Hans Biomed is 042520.

  • What is the current stock price of Hans Biomed?

    As of 20-Jun-2025 the stock price of Hans Biomed is $6.55.

  • What is the current market cap of Hans Biomed?

    The current market capitalization of Hans Biomed is $85.1M.

  • What is Hans Biomed’s current revenue?

    The trailing twelve month revenue for Hans Biomed is $60.5M.

  • What is Hans Biomed’s annual earnings per share (EPS)?

    Hans Biomed’s EPS for 12 months was -$0.37.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »